Home > Financial Ratios > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EBIT Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Margin(%) 19.6720.4629.3036.9038.64

What is the latest EBIT Margin ratio of GLAND PHARMA ?

The latest EBIT Margin ratio of GLAND PHARMA is 19.67 based on Mar2025 Consolidated results.
Year EBIT Margin
Mar202519.67
Mar202420.46
Mar202329.30
Mar202236.90
Mar202138.64

How is EBIT Margin of GLAND PHARMA Trending?

Years EBIT Margin % Change
Mar2025 19.67
-3.86
Mar2024 20.46
-30.17
Mar2023 29.3
-20.60
Mar2022 36.9
-4.50
Mar2021 38.64 -

Other Financial Ratios of GLAND PHARMA


Compare EBIT Margin ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹31,911.9 Cr -1.4% 4.2% -4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,917.0 Cr -1.2% -3.6% -8.6% Stock Analytics
DIVIS LABORATORIES ₹158,982.0 Cr -6.6% -12.4% 22.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,306.0 Cr 0.7% 9.1% 7.2% Stock Analytics
CIPLA ₹121,442.0 Cr 0.3% 1.2% -5.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,752.0 Cr 0.4% -2.8% -12.7% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.4%

4.2%

-4.6%

SENSEX

-0.5%

-3.1%

1.4%


You may also like the below Video Courses